BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ROS1, ROS, 6098, ENSG00000047936, P08922, MCF3, RP1-179P9_1 AND Treatment
13878 results:

  • 1. CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity.
    Ma J; Ren D; Wang Z; Li W; Li L; Liu T; Ye Q; Lei Y; Jian Y; Ma B; Fan Y; Liu J; Gao Y; Jin X; Huang H; Li L
    Sci Adv; 2024 May; 10(21):eadk8908. PubMed ID: 38781342
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells.
    Wu P; Wang X; Yin M; Zhu W; Chen Z; Zhang Y; Jiang Z; Shi L; Zhu Q
    Int J Nanomedicine; 2024; 19():4465-4493. PubMed ID: 38779103
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trials.
    Arias-Lorza AM; Costello JR; Hingorani SR; Von Hoff DD; Korn RL; Raghunand N
    Sci Rep; 2024 May; 14(1):11570. PubMed ID: 38773189
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Role of peritumoral tissue analysis in predicting characteristics of hepatocellular carcinoma using ultrasound-based radiomics.
    Qian H; Huang Y; Xu L; Fu H; Lu B
    Sci Rep; 2024 May; 14(1):11538. PubMed ID: 38773179
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inside stent placement is suitable for preoperative biliary drainage in patients with perihilar cholangiocarcinoma.
    Yamada R; Kuriyama N; Tanaka T; Nose K; Nakamura Y; Miwata T; Tsuboi J; Mizuno S; Nakagawa H
    BMC Gastroenterol; 2024 May; 24(1):174. PubMed ID: 38769494
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
    Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
    J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact on Long-term Survival of a Standardized Histopathological Protocol on the R1 Incidence in Pancreatoduodenectomy for pancreatic Ductal Adenocarcinoma.
    Moiş E; Graur F; Puia C; Vlad I; Moldovan S; Ursu CP; Nechita VI; Vălean D; Furcea L; Puia A; Zaharie F; Popa C; Bodea R; Iancu C; Rusu I; Hajjar NA
    Chirurgia (Bucur); 2024 Apr; 119(2):171-183. PubMed ID: 38743830
    [No Abstract]    [Full Text] [Related]  

  • 8. Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.
    Kasuga R; Taniki N; Chu PS; Tamura M; Tabuchi T; Yamaguchi A; Hayatsu S; Koizumi J; Ojiro K; Hoshi H; Kaneko F; Morikawa R; Noguchi F; Yamataka K; Usui S; Ebinuma H; Itano O; Hasegawa Y; Abe Y; Kitago M; Inoue M; Nakatsuka S; Jinzaki M; Kitagawa Y; Kanai T; Nakamoto N
    Sci Rep; 2024 May; 14(1):10896. PubMed ID: 38740983
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MKLN1-AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF-1α through miR-185-5p/TEAD1 pathway.
    Chen J; Li L; Feng Y; Zhao Y; Sun F; Zhou X; Yiqi D; Li Z; Kong F; Kong X
    Cell Biol Toxicol; 2024 May; 40(1):30. PubMed ID: 38740637
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Enrichment and Evaluation of Antitumor Properties of Total Flavonoids from
    Yang S; Chu G; Wu J; Zhang G; Du L; Lin R
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731467
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The influence of delayed gastric emptying on quality of life after partial duodenopancreatectomy.
    Klein M; Warschkow R; Ukegjini K; Krstic D; Burri P; Chatziisaak D; Steffen T; Schmied B; Probst P; Tarantino I
    Langenbecks Arch Surg; 2024 May; 409(1):155. PubMed ID: 38727871
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Exosomal PD-L1 in cancer and other fields: recent advances and perspectives.
    Lu MM; Yang Y
    Front Immunol; 2024; 15():1395332. PubMed ID: 38726017
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer.
    Zhao J; Wang H; Chen J; Wang C; Gong N; Zhou F; Li X; Cao Y; Zhang H; Wang W; Zheng H; Zhang C
    Biochem Biophys Res Commun; 2024 Jul; 718():149931. PubMed ID: 38723415
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of pancreatic Carcinomas: In Search of Therapeutic Targets.
    Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
    JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immune checkpoint inhibitor associated diarrhoea.
    Al-Hussainy A; Adams J; Simmons J; Kennedy J
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38719255
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Analysis of factors affecting the prognosis of patients with pancreatic cancer patients with obstructive jaundice].
    Zhang L; Li M; Sun QF; Yu HP
    Zhonghua Nei Ke Za Zhi; 2024 May; 63(5):474-479. PubMed ID: 38715484
    [No Abstract]    [Full Text] [Related]  

  • 17. Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
    Zhang P; Chen Z; Shi S; Li Z; Ye F; Song L; Zhang Y; Yin F; Zhang X; Xu J; Cheng Y; Su W; Shi M; Fan S; Tan P; Zhong C; Lu M; Shen L
    Cancer Immunol Immunother; 2024 May; 73(7):119. PubMed ID: 38713205
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study.
    Hompland I; Boye K; Wiedswang AM; Papakonstantinou A; Røsok B; Joensuu H; Bruland Ø
    Acta Oncol; 2024 May; 63():288-293. PubMed ID: 38712513
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. treatment strategies for borderline resectable pancreatic neuroendocrine tumors: a narrative review.
    Chang JY; Ruff SM; Cloyd JM
    Chin Clin Oncol; 2024 Apr; 13(2):25. PubMed ID: 38711178
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Significance of
    Lin H; Wang J; Shi Q; Wu M
    PeerJ; 2024; 12():e17338. PubMed ID: 38708353
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 694.